Fuji Pharma Co.,Ltd. (4554) — research page
JP · jp-cm-kg/TSE-PRIME/4554 · as of 2026-11-06
Identity and listing
Fuji Pharma Co.,Ltd. is listed on the Prime Market under ticker 4554, ISIN JP3816200004 and LEI 529900L1XVCEHVKHAM60. Its security type is Corporate, its segment is not on the record, its sector is 3250 Pharmaceutical and its jurisdiction is Japan (EDINET domestic filer). Its listing status is listed, not halted.
| field | value | source · read date |
|---|---|---|
| name | Fuji Pharma Co.,Ltd. | source · 2026-11-06 |
| exchange | Prime Market | source · 2026-11-06 |
| ticker | 4554 | source · 2026-11-06 |
| ISIN | JP3816200004 | source · 2026-11-06 |
| LEI | 529900L1XVCEHVKHAM60 | source · 2026-11-08 |
| security type | Corporate | source · 2026-11-06 |
| segment | not on the record | |
| sector | 3250 Pharmaceutical | source · 2026-11-06 |
| jurisdiction | Japan (EDINET domestic filer) | source · 2026-11-06 |
| status | listed, not halted | source · 2026-11-08 |
The disclosure read
The record holds 6 filings in the twelve months to 2026-11-06, on 3 filing days. Of the filings, 1 is ad hoc, 3 are regulatory filings and 2 are results. The median gap between filing days is 73.0 days. The latest filing is dated 2026-05-13, a regulatory filing, 177 days before the record date. The Prime Market median is 29.0 days of cadence gap, 10 filings and 70.0 days of latency across 1557 issuers. The 3250 Pharmaceutical median is 49.5 days of cadence gap, 8.0 filings and 85.0 days of latency across 80 issuers.
| filings | median gap between filing days | days from latest filing to as-of | |
|---|---|---|---|
| this issuer | 6 | 73 | 177 |
| exchange median: Prime Market (1557 issuers) | 10 | 29 | 70 |
| sector median: 3250 Pharmaceutical (80 issuers) | 8 | 49.5 | 85 |
| date | type | category | filing |
|---|---|---|---|
| 2026-05-13 | regulatory_filing | 135 | 確認書 |
| 2026-05-13 | results | 半期報告書 (half-year report) | 半期報告書－第62期(2025/10/01－2026/09/30) |
| 2025-12-22 | ad_hoc | 臨時報告書 (extraordinary report) | 臨時報告書 |
| 2025-12-18 | regulatory_filing | 135 | 確認書 |
| 2025-12-18 | regulatory_filing | 235 | 内部統制報告書－第61期(2024/10/01－2025/09/30) |
window 2025-11-06 to 2026-11-06 · the node's disclosure lines, as get_filings serves them
Auditor
The auditor of record is 有限責任 あずさ監査法人. Its location is not on the record. Auditor changes are not on the record, as this register has no lifecycle type map yet.
Events and halts
Listing, delisting, name change, domicile change and segment move are not on the record, as this register has no lifecycle type map yet. The halt flag is listed, not halted.
Orderability
For the client category Qualified Institutional Investors, the signal is not determinable, because the rule states a product scope and the subject's record carries no instrument class to place within it. The rule version is acm-68000/jp/suitability-principle-fiea-article-40/r1, and the chapter is as of 2026-11-04.
| client category | outcome |
|---|---|
| Qualified Institutional Investors | not determinable: the rule states a product scope and the subject's record carries no instrument class to place within it |
rule acm-68000/jp/suitability-principle-fiea-article-40/r1 · chapter as of 2026-11-04 · the full outcome: get_orderability
Coverage
The issuer's investor-relations page names 3 research houses: Tokai Tokyo Intelligence Laboratory Co., Ltd., Toyo Securities Co., Ltd. and Mizuho Securities Co., Ltd.
| research house | analyst | source · read date |
|---|---|---|
| Tokai Tokyo Intelligence Laboratory Co., Ltd. | Masao Yoshida | issuer page · 2026-11-12 |
| Toyo Securities Co., Ltd. | Eiichiro Haizuka | issuer page · 2026-11-12 |
| Mizuho Securities Co., Ltd. | Yuriko Ishida | issuer page · 2026-11-12 |
Open research
The record holds 1 openly published research note: FISCO Ltd., dated 2026-01-20.
| date | publisher | note | kind |
|---|---|---|---|
| 2026-01-20 | FISCO Ltd. | FY2025_Company Research and Analysis Report - Fuji Pharma Co., Ltd. | issuer-sponsored |
Licensed
Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.
| licensor | entitlement | title | date | source |
|---|---|---|---|---|
| none loaded |
As-of depth
The market's vintage is not sealed. No issuer years are sealed, and the market's earliest sealed date and the live record start date are not on the record.
Sources
11 source pages are named on this page; every value above carries its own source page and read date in the numbers.
- 10.1
- https://www.jpx.co.jp/english/markets/statistics-equities/misc/tvdivq0000001vg2-att/data_e.xlsx (identity.exchange)
- 10.2
- https://mapping.gleif.org/api/v2/isin-lei/latest (identity.isin)
- 10.3
- https://disclosure2dl.edinet-fsa.go.jp/searchdocument/codelist/Edinetcode.zip (identity.jurisdiction)
- 10.4
- https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei)
- 10.5
- https://mcp.jp-cm-kg.ai/events/TSE-PRIME/4554 (the disclosure lines)
- 10.6
- https://www.jpx.co.jp/markets/equities/suspended/index.html (the halt flag)
- 10.7
- https://disclosure2.edinet-fsa.go.jp/WZEK0040.aspx?S100XAU2 (the auditor)
- 10.8
- https://mcp.jp-cm-kg.ai/book/aio.json (the orderability chapter)
- 10.9
- https://www.fujipharma.jp/english/ir/stock/ (coverage)
- 10.10
- https://www.fujipharma.jp/english/__upload/EN_sr_report_202601.pdf (open research)
- 10.11
- https://mcp.jp-cm-kg.ai/record/TSE-PRIME/4554 (the record)
Read it by agent
The same page, signed and receipted: get_research at https://mcp.getresearch.ai/mcp with {"isin":"JP3816200004"}. Twins: .md · .json. Written: Claude through the platform account, Haiku class; one pass; checked against the numbers. Page hash sha256:d932dc2763d398c3.